EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver Regeneration Following Thermal Ablation Using Nanocarrier Mediated Targeted Mesenchymal Stem Cell Therapy

Prasoon P Mohan, Sapna Deo, Zhao-Jun Liu, Emre Dikici, Hugo Kaneku, Doyoung Chang, Monica Garcia-Buitrago, Hamed Jalaeian, Elnaz Zeynaloo, Yulexi Y Ortiz, Yan Li, Shivank Bhatia und 2 weitere

CardioVascular and Interventional Radiology · 2024

DOI: 10.1007/s00270-024-03862-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2024. Verfasst von Prasoon P Mohan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, University of Miami Miller School of Medicine, Miami, FL, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Liver Regeneration, Radiofrequency Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Foundation for the National Institutes of Health, Wallace H. Coulter Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To test the efficacy of nanocarrier (NC) mediated mesenchymal stem cell (MSC) therapy for liver regeneration following thermal ablation of porcine livers. Materials and Methods Liver radiofrequency ablation was performed in 18 swines divided into MSC, MSC + NC and control groups. The test groups received infusion of MSC or MSC + NC labeled with enhanced green fluorescent protein (eGFP) via hepatic artery. MSC + NC group had MSCs coated with dendrimer nanocarrier complexed with I-Domain of lymphocyte function-associated antigen-1 (LFA-1). Nanocarriers direct homing of MSCs by binding to its counterpart protein, intercellular adhesion molecule-1 (ICAM-1), which is overexpressed at the periablation margins from inflammation. Ablation cavity reduction by CT volumetry was used as surrogate marker for liver regeneration. Cell proliferation was assessed with Ki67 and HepPar-1 stains. GFP identified MSC derived cells.

Results

Total number of ablations in control animals were 13 across 4 animals. In the MSC group, there were 23 ablations across 6 animals, and in MSC + NC group there were 21 ablations across 6 animals. Ablation cavity volume reduction from day 0 to 30 were 64.4 ± 15.0%, 61.5 ± 12.9% and 80.3 ± 9.4% for control, MSC and MSC + NC groups, respectively (MSC + NC vs MSC: p < 0.001, MSC + NC vs. control: p = 0.001). GFP + cell count at margins was 426.8 ± 193.2 for MSC group and 498.6 ± 235.2 for MSC + NC group ( p = 0.01). The mean Ki67 and HepPar-1 staining at margins were 9.81 ± 4.5% and 6.12 ± 4.2% for MSC + NC group versus 7.59 ± 3.7% and 5.09 ± 3.7% for MSC group, respectively ( P < 0.001 and P = 0.09, respectively).

Conclusion

Nanocarrier-mediated MSC therapy promotes liver regeneration by engrafting MSCs at ablation margins, potentially making liver-directed therapy viable for patients with severe liver dysfunction. This technology may also benefit other solid organs. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationLiver RegenerationRadiofrequency AblationAnimalsSwineLiverGreen Fluorescent ProteinsNanoparticlesMesenchymal Stem CellsDisease Models, Animal

Stichwörter der Autor:innen

Liver regenerationNanocarrierStem cellsThermal ablation

Substanzen

Green Fluorescent Proteins

Autor:innen und Institutionen

  • Department of Interventional Radiology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Department of Interventional Radiology, UMHC-SCC, 1475 NW 12th Ave., Miami, FL, 33136, USA.
  • Department of Biochemistry, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Department of Biochemistry, University of Miami Miller School of Medicine, Miami, FL, USA. sdaunert@med.miami.edu.
  • Department of Interventional Radiology, UMHC-SCC, 1475 NW 12th Ave., Miami, FL, 33136, USA. sdaunert@med.miami.edu.

Förderung

  • NHLBI NIH HHS
  • Foundation for the National Institutes of Health
  • Wallace H. Coulter Foundation

Zitieren

APA

Mohan, P. P., Deo, S., Liu, Z. J., Dikici, E., Kaneku, H., Chang, D., Garcia-Buitrago, M., Jalaeian, H., Zeynaloo, E., Ortiz, Y. Y., Li, Y., Bhatia, S., Velazquez, O., & Daunert, S. (2024). Liver Regeneration Following Thermal Ablation Using Nanocarrier Mediated Targeted Mesenchymal Stem Cell Therapy. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-024-03862-2

Vancouver

Mohan PP, Deo S, Liu ZJ, Dikici E, Kaneku H, Chang D, et al. Liver Regeneration Following Thermal Ablation Using Nanocarrier Mediated Targeted Mesenchymal Stem Cell Therapy. CardioVascular and Interventional Radiology. 2024. doi:10.1007/s00270-024-03862-2

BibTeX
@article{Mohan2024,
  author = {Mohan, Prasoon P and Deo, Sapna and Liu, Zhao-Jun and Dikici, Emre and Kaneku, Hugo and Chang, Doyoung and Garcia-Buitrago, Monica and Jalaeian, Hamed and Zeynaloo, Elnaz and Ortiz, Yulexi Y and Li, Yan and Bhatia, Shivank and Velazquez, Omaida and Daunert, Sylvia},
  title = {Liver Regeneration Following Thermal Ablation Using Nanocarrier Mediated Targeted Mesenchymal Stem Cell Therapy},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  doi = {10.1007/s00270-024-03862-2}
}
Kostenlos starten →